Variable | Level | Q1 21.2–37.7% (n = 254) | Q2 47.1–55.7% (n = 158) | Q3 60.0–64.7% (n = 350) | Q4 69.0–81.7% (n = 313) | Main effects p-valuea |
---|---|---|---|---|---|---|
Primary active cancer | ||||||
 | Do not know | 4 (2%) | 5 (3%) | 5 (1%) | 3 (1%) |  |
Hematologic | 38 (15%) | 24 (15%) | 50 (14%) | 42 (13%) | Â | |
Solid | 208 (82%) | 128 (81%) | 294 (84%) | 266 (85%) | Â | |
Missing | 4 (2%) | 1 (1%) | 1 (0%) | 2 (1%) | 0.966 | |
Cancer-related therapies within previous 30Â days | ||||||
 | No | 83 (33%) | 35 (22%) | 103 (29%) | 73 (23%) |  |
Yes | 166 (65%) | 123 (78%) | 246 (70%) | 238 (76%) | Â | |
Missing | 5 (2%) | 0 (0%) | 1 (0%) | 2 (1%) | 0.139 | |
Traditional chemotherapy | No | 155 (61%) | 75 (47%) | 208 (59%) | 142 (45%) | Â |
Yes | 99 (39%) | 83 (53%) | 142 (41%) | 171 (55%) | 0.001 | |
Targeted drug therapy | No | 205 (81%) | 133 (84%) | 285 (81%) | 274 (88%) | Â |
Yes | 49 (19%) | 25 (16%) | 65 (19%) | 39 (12%) | 0.341 | |
Systemic corticosteroids | No | 229 (90%) | 135 (85%) | 299 (85%) | 268 (86%) | Â |
Yes | 25 (10%) | 23 (15%) | 51 (15%) | 45 (14%) | 0.718 | |
Radiotherapy | No | 237 (93%) | 136 (86%) | 320 (91%) | 274 (88%) | Â |
Yes | 17 (7%) | 22 (14%) | 30 (9%) | 39 (12%) | 0.004 | |
Surgery for cancer | No | 225 (89%) | 143 (91%) | 327 (93%) | 295 (94%) | Â |
Yes | 29 (11%) | 15 (9%) | 23 (7%) | 18 (6%) | 0.202 | |
None of the above | No | 254 (100%) | 157 (99%) | 345 (99%) | 311 (99%) | Â |
Yes | 0 (0%) | 1 (1%) | 5 (1%) | 2 (1%) | b | |
Do you have a living will or advance directive? | ||||||
 | Do not know | 11 (4%) | 12 (8%) | 34 (10%) | 12 (4%) |  |
No | 106 (42%) | 80 (51%) | 157 (45%) | 152 (49%) | Â | |
Yes | 132 (52%) | 65 (41%) | 158 (45%) | 147 (47%) | Â | |
Missing | 5 (2%) | 1 (1%) | 1 (0%) | 2 (1%) | 0.175 | |
Do you currently receive care services? | ||||||
 | No | 180 (71%) | 147 (93%) | 320 (91%) | 280 (89%) |  |
Yes | 18 (7%) | 10 (6%) | 27 (8%) | 31 (10%) | Â | |
Missing | 56 (22%) | 1 (1%) | 3 (1%) | 2 (1%) | 0.879 | |
Do you currently receive hospice care? | ||||||
 | No | 243 (96%) | 154 (97%) | 340 (97%) | 307 (98%) |  |
Yes | 4 (2%) | 3 (2%) | 9 (3%) | 4 (1%) | Â | |
Missing | 7 (3%) | 1 (1%) | 1 (0%) | 2 (1%) | 0.673 |